U-GRFS

Q:GRFS - GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 - Website unknown - click to update

08:41:06 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
GRFS - Q	4.4	6.42	·	6.48	1.0	6.30			5.8	18	9		12.1499 5.3001	08:02:59	Apr 19	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - All 9 today

More trades...

Time ET	Ex	Price	Change	Volume
08:02:59	Q	6.4207	0.1207	100
08:00:06	Q	6.49	0.19	15
08:00:06	Q	6.49	0.19	10
08:00:04	Q	6.45	0.15	10
08:00:03	Q	6.5297	0.2297	100
08:00:02	Q	6.55	0.25	200
08:00:02	Q	6.46	0.16	5
07:02:02	Q	6.44	0.14	630
07:02:02	Q	6.44	0.14	370
06:23:17	Q	6.52	0.22	146

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-19 16:42	U:GRFS	News Release200	Grifols 2023 Annual Report on Form 20-F filed with the SEC
2024-04-18 09:30	U:GRFS	News Release200	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
2024-04-04 04:00	U:GRFS	News Release200	Grifols Procleix ArboPlex Assay(TM) Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Date ET

Symbol

Type

Headline

2024-04-19 16:42

U:GRFS

News Release

Grifols 2023 Annual Report on Form 20-F filed with the SEC

2024-04-18 09:30

U:GRFS

News Release

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

2024-04-04 04:00

U:GRFS

News Release

Grifols Procleix ArboPlex Assay(TM) Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening